Overview
Fernando Lecanda practices in Pamplona, Spain. Mr. Lecanda is rated as an Advanced expert by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Osteosarcoma, Adult Soft Tissue Sarcoma, Lung Metastases, and Osteolysis Syndrome Recessive.
His clinical research consists of co-authoring 63 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 25 articles in the study of Adult Soft Tissue Sarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- OsteosarcomaMr. Lecanda isDistinguished. Learn about Osteosarcoma.
- Advanced
- Adult Soft Tissue SarcomaMr. Lecanda isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorMr. Lecanda isAdvanced. Learn about Bone Tumor.
- Lung CancerMr. Lecanda isAdvanced. Learn about Lung Cancer.
- Lung MetastasesMr. Lecanda isAdvanced. Learn about Lung Metastases.
- Osteolysis Syndrome RecessiveMr. Lecanda isAdvanced. Learn about Osteolysis Syndrome Recessive.
- Experienced
- Breast CancerMr. Lecanda isExperienced. Learn about Breast Cancer.
- Lung AdenocarcinomaMr. Lecanda isExperienced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Lecanda isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pancreatic CancerMr. Lecanda isExperienced. Learn about Pancreatic Cancer.